Last reviewed · How we verify

NCT05602077: SONOELB

Accuracy of Sonography in Elbow Trauma

Completed NA Last updated 16 April 2026
What this trial tests

NA trial testing POCUS in Elbow Fracture in 90 participants. Completed in 31 March 2025.

Timeline
1 November 2022
Primary endpoint
31 March 2025
31 March 2025

Quick facts

Lead sponsorEckehart SCHÖLL
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment90
Start date1 November 2022
Primary completion31 March 2025
Estimated completion31 March 2025
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Eckehart SCHÖLL — full company profile →

Who can join

18 and older, any sex, with Elbow Fracture or Radial Head Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

X-rays (XR) are today the standard modality for the diagnosis of bone fractures in the lower or upper limbs in the emergency room. Point-of-care ultrasound (POCUS) is an alternative with some obvious advantages especially in the emergency room setting: It does not require the patient to fix the bone of interest in a stable position, allows observing the bone and joints under movement by the patient, can be performed at bedside, and avoids the exposure to radiation. The advances in ultrasound technology has increased the interest in using POCUS as an alternative to XR in recent years. POCUS is used routinely prior to XR at the ORTHO-NOTFALL of the Merian Iselin Klinik Basel (MIK) in patients with suspicion for an indirect elbow trauma. It is the aim of this project to use this constellation in order to contribute to a systematic comparison of the value of the two modalities with the long-term aim to establish POCUS as the first-line diagnostic tool. As a fist project, the SONOELB study was initiated. This study aims at a comparison of the diagnostic accuracy between XR and POCUS using CT as reference. The project started in October 2022 and aims at enrolling 130 patients until March 2025. The project is financially supported by the Merian Iselin Science Research PLC.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of POCUS

Trials testing the same drug.

Other Eckehart SCHÖLL trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05602077.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing